Literature DB >> 2328002

Deficient lysosomal carboxypeptidase activity in galactosialidosis.

J Tranchemontagne1, L Michaud, M Potier.   

Abstract

In the lysosome, the glycosidases neuraminidase (EC 3.2.1.18) and beta-galactosidase (EC 3.2.1.23) are associated to a 52 kDa "protective protein" to form a large multi-enzymatic complex. Deficient synthesis or inactivation of this protective protein causes galactosialidosis, a lysosomal storage disorder in man in which both neuraminidase and beta-galactosidase activities are deficient. Since the protective protein possesses extensive sequence homology with carboxypeptidase Y (carb Y) and the KEX 1 gene product from yeast, we have used the artificial substrate N-CBZ-Phe-Leu to detect and characterize the peptidase activity of the lysosomal carboxypeptidase (carb L). Using both a purified preparation of the lysosomal multi-enzymatic complex and cultured skin fibroblasts of patients affected with galactosialidosis, we demonstrate that the 52 kDa protective protein is responsible for carb L activity. The fibroblasts of three patients affected with late infantile and juvenile galactosialidosis were found to be deficient in carb L activity (1.4% of normal mean value).

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2328002     DOI: 10.1016/0006-291x(90)91669-j

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

Review 1.  The early and late processing of lysosomal enzymes: proteolysis and compartmentation.

Authors:  A Hasilik
Journal:  Experientia       Date:  1992-02-15

2.  Cathepsin A is the major hydrolase catalyzing the intracellular hydrolysis of the antiretroviral nucleotide phosphonoamidate prodrugs GS-7340 and GS-9131.

Authors:  Gabriel Birkus; Ruth Wang; Xiaohong Liu; Nilima Kutty; Holly MacArthur; Tomas Cihlar; Craig Gibbs; Swami Swaminathan; William Lee; Martin McDermott
Journal:  Antimicrob Agents Chemother       Date:  2006-12-04       Impact factor: 5.191

3.  Ultrastructural and immunocytochemical study of skin fibroblasts from normal and sialidosis patients.

Authors:  S Igdoura; C Morales; J Tranchemontagne; M Potier
Journal:  Cell Tissue Res       Date:  1994-12       Impact factor: 5.249

4.  Stable expression of protective protein/cathepsin A-green fluorescent protein fusion genes in a fibroblastic cell line from a galactosialidosis patient. Model system for revealing the intracellular transport of normal and mutated lysosomal enzymes.

Authors:  Y Naganawa; K Itoh; M Shimmoto; S Kamei; K Takiguchi; H Doi; H Sakuraba
Journal:  Biochem J       Date:  1999-06-01       Impact factor: 3.857

5.  An infant with multiple congenital abnormalities and biochemical findings suggesting a variant of galactosialidosis.

Authors:  B Say; F A Hommes; S A Malik; N J Carpenter
Journal:  J Med Genet       Date:  1992-06       Impact factor: 6.318

6.  Role of cathepsin A and lysosomes in the intracellular activation of novel antipapillomavirus agent GS-9191.

Authors:  Gabriel Birkus; Nilima Kutty; Christian R Frey; Riri Shribata; Tsuifen Chou; Carston Wagner; Martin McDermott; Tomas Cihlar
Journal:  Antimicrob Agents Chemother       Date:  2011-03-07       Impact factor: 5.191

7.  Adult-onset lysosomal storage disease in a Schipperke dog: clinical, morphological and biochemical studies.

Authors:  K Knowles; J Alroy; M Castagnaro; S S Raghavan; R M Jakowski; G O Freden
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

8.  Characteristics of the beta-galactosidase-carboxypeptidase complex in GM1-gangliosidosis and beta-galactosialidosis fibroblasts.

Authors:  R M D'Agrosa; M Hubbes; S Zhang; R Shankaran; J W Callahan
Journal:  Biochem J       Date:  1992-08-01       Impact factor: 3.857

9.  Intracellular Activation of Tenofovir Alafenamide and the Effect of Viral and Host Protease Inhibitors.

Authors:  Gabriel Birkus; Rujuta A Bam; Madeleine Willkom; Christian R Frey; Luong Tsai; Kirsten M Stray; Stephen R Yant; Tomas Cihlar
Journal:  Antimicrob Agents Chemother       Date:  2015-10-26       Impact factor: 5.191

10.  Protective protein gene mutations in galactosialidosis.

Authors:  M Shimmoto; Y Fukuhara; K Itoh; A Oshima; H Sakuraba; Y Suzuki
Journal:  J Clin Invest       Date:  1993-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.